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The initial thoracic organ allocation scheme was 7-tiered,based on that used for renal allocations. The first revision,in 1989, was to a 2-tiered system. Because of its inade-quacy in addressing certain patients and potential for
abuse, and before widespread use of ventricular assist devices, the
United Network for Organ Sharing (UNOS) in 1999 modified its
thoracic organ allocation scheme from a 2-tiered to a 3-tiered system. 1
As contemporary medical and nontransplant surgical therapy
for heart failure continues to improve, the benefit of heart trans-
plantation in patients with UNOS status 2 heart disease has come
under scrutiny. Recently, UNOS proposed a modification for the
heart transplant allocation scheme that increases availability of
hearts to patients with status 1A and 1B heart disease (Table 1).2
This study sought to evaluate the outcome of UNOS status 2
registrants in the era of modern medical management and under
the current UNOS scheme for heart transplantation.
Materials and Methods
The study cohort included all patients aged more than 18 years
who were added to the UNOS/Organ Procurement and Transplan-
tation Network (OPTN) registry between January 1, 2001, and
December 31, 2003. Demographic and clinical information were
collated by year, UNOS status at listing, and UNOS status at
removal. Data obtained included age, diagnosis, change in status,
removal from the waiting list for any reason, and waiting list
duration. Events of interest included transplantation, upgrade in
status to 1A or 1B, removal from the waiting list for any reason,
and death.
Results
From 2001 to 2003, there were 5467 heart transplantations per-
formed in the United States. During this same time period, there
were 1484 patients awaiting transplantation who died. There were
4184 new UNOS status 2 registrants during the study period. The
average age was 51.4 years. Diagnoses were ischemic cardiomy-
opathy (42.4%), followed by idiopathic cardiomyopathy (30.5%),
coronary artery disease (4.8%), congenital heart disease (3.8%),
valvular heart disease (3.0%), and all others (15.3%).
Improvement leading to removal from the UNOS registry oc-
curred in 176 patients (4.2%). Median waiting list time was 406
days. A total of 1265 patients (30.2%) required an upgrade to
status 1A or 1B. There were 85 patients (2.0%) whose status was
changed to “too sick to transplant” or “medically unsuitable.”
While waiting for transplantation, 426 patients (10.2%) died (Ta-
ble 2). The average number of days on the waiting list before death
was 152.
Discussion
The transplant community’s generalized impression is that patients
listed as UNOS status 2 remain stable for a prolonged period of
time. With advances in modern medical therapy, including neuro-
hormonal modulation and defibrillator/biventricular pacer therapy,
the survival benefit of heart transplantation has been investigated.
Patients listed as UNOS status 2 who are treated medically have
1-year survival comparable to those who undergo transplantation.3
The survival benefit from heart transplantation seems limited to
those patients with the highest risk of dying, and perhaps restric-
tion of transplantation to the sickest patients would improve post-
transplant survival.4 It has been proposed that patients listed as
UNOS status 2 may not derive benefit from transplantation unless
an upgrade in status occurs, as in one study, 1-year survival in
patients listed as status 2 was equivalent for those undergoing
transplantation versus those remaining on the waiting list.3
Patients listed as UNOS status 2 represent a heterogenous
group, some of whom will likely benefit from early transplantation
rather than after clinical deterioration. According to the data pre-
sented here, more than 40% of patients listed as UNOS status 2 had
deterioration in their clinical status. There were 2243 patients who
underwent heart transplantation after initial listing as UNOS status
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2, of whom 1083 (48.3%) were upgraded in UNOS status by the
time of transplantation. Furthermore, of 1265 patients who were
upgraded, 87 (6.9%) died awaiting transplantation. Although some
patients who deteriorate in UNOS status may be salvaged with
mechanical support, the associated morbidity and mortality with
this type of procedure are not negligible. Single-center experience
at Washington University corroborates these data and suggests that
patients listed as UNOS status 2 continue to derive an overall
benefit from transplantation.5
The proposed UNOS modification to the 1999 scheme will
likely improve overall survival among patients on the heart trans-
plant waiting list, at the expense of some patients listed as UNOS
status 2. On the basis of these data, it is ethically unjustifiable to
conduct a prospective randomized trial to evaluate best medical
therapy versus transplantation for patients listed as UNOS status 2.
Furthermore, it may be premature to divert donor organs away
from local patients listed as UNOS status 2. Until variables are
identified to better stratify patients listed as UNOS status 2, caution
must be exercised.
We acknowledge the efforts of the staff at UNOS for their
assistance in obtaining data from the UNOS/OPTN database.
References
1. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules:
historical background and implication for transplantation management.
J Heart Lung Transplant. 1999;18:1065-70.
2. United Network for Organ Sharing. Available at: https://www.unos.org.
Accessed 2005.
3. Jiminez J, Edwards LB, Higgins R, Bauerlein J, Pham S, Mallon S.
Should stable UNOS Status 2 patients be transplanted? J Heart Lung
Transplant. 2005;24:178-83.
4. Deng MC, DeMeester JMJ, Smits JMA, Heinecke J, Scheld HH. Effect of
receiving a heart transplant: analysis of a national cohort entered on to a
waiting list, stratified by heart failure severity. BMJ. 2000;321:540-5.
5. Shah NR, Ewald GA, Horstmanshof DA, Geltman EM, Moorehead SL,
Moazami N. Should UNOS Status 2 patients be transplanted? J Heart
Lung Transplant. 2005;24(2S):S69.
TABLE 1. Sequence of heart allocation
Current scheme Proposed scheme
Local 1. Status 1A patients 1. Status 1A patients
2. Status 1B patients 2. Status 1B patients
3. Status 2 patients
Zone A 4. Status 1A patients 3. Status 1A patients
5. Status 1B patients 4. Status 1B patients
Local 5. Status 2 patients
Zone B 6. Status 1A patients 6. Status 1A patients
7. Status 1B patients
7. Status 1B patients
Zone A 8. Status 2 patients
8. Status 2 patients
Zone B 9. Status 2 patients
9. Status 2 patients
Zone C 10. Status 1A patients 10. Status 1A patients
11. Status 1B patients 11. Status 1B patients
12. Status 2 patients
12. Status 2 patients
Zone D 13. Status 1A patients 13. Status 1A patients
14. Status 1B patients 14. Status 1B patients
15. Status 2 patients 15. Status 2 patients
Local, Local to donor hospital; zone A, within 500-mile radius of donor
hospital; zone B, within 1000-mile radius of donor hospital; zone C, within
1500-mile radius of donor hospital; zone D, beyond 1500 miles from donor
hospital.
TABLE 2. Change in clinical condition for UNOS
status 2 registrants 2001 to 2003
Year 2001 2002 2003 Total
Total UNOS status 2
registrants 1549 1363 1272 4184
Condition improved 85 (5.5) 64 (4.7) 27 (2.1) 176 (4.2)
Condition
deteriorated,
too sick to
undergo
transplantation 44 (2.8) 19 (1.4) 12 (0.9) 75 (1.8)
Medically unsuitable 5 (0.3) 3 (0.2) 2 (0.2) 10 (0.2)
Died (awaiting
transplant)
Total 192 (12.4) 130 (9.5) 104 (8.2) 426 (10.2)
As status 1A 26 (1.7) 9 (0.7) 9 (0.7) 44 (1.1)
As status 1B 18 (1.2) 12 (0.9) 13 (1.0) 43 (1.0)
As status 2 83 (5.4) 62 (4.5) 40 (3.1) 185 (4.4)
As temporarily
inactive 65 (4.2) 47 (3.4) 42 (3.3) 154 (3.7)
Underwent
transplantation
Total 876 (56.6) 757 (55.5) 610 (48.0) 2243 (53.6)
As status 1A 128 (8.3) 146 (10.7) 115 (9.0) 389 (9.3)
As status 1B 297 (19.2) 238 (17.5) 159 (12.5) 694 (16.6)
As status 2 451 (29.1) 373 (27.4) 336 (26.4) 1160 (27.7)
Total upgrades to
status 1A 160 (10.3) 158 (11.6) 131 (10.3) 449 (10.7)
Total upgrades to
status 1B 336 (21.7) 271 (19.9) 209 (16.4) 816 (19.5)
UNOS, United Network for Organ Sharing; OPTN , Organ Procurement and
Transplantation Network. Based on OPTN data as of September 17, 2004.
Total numbers for each year with percentages in parentheses.
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